We are live on ! Find out more
SGTX

Sigilon Therapeutics, Inc. Common Stock
SGTX

Delisted

SGTX was delisted on the 10th of August, 2023.

Back to rankings

45 hedge funds and large institutions have $942M invested in Sigilon Therapeutics, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 45 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
+45
Holders Change %
–
% of All Funds
0.8%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.07%
New
45
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FP
Flagship Pioneering
Massachusetts
+$362M
2
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board
Ontario, Canada
+$51.8M
3
BlackRock
BlackRock
New York
+$38.8M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$33.3M
5
HP
Harbourvest Partners
Massachusetts
+$25.9M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
FP
1
Flagship Pioneering
Massachusetts
$498M +$362M +797,721 New
Canada Pension Plan Investment Board
2
Canada Pension Plan Investment Board
Ontario, Canada
$71.3M +$51.8M +114,245 New
BlackRock
3
BlackRock
New York
$53.4M +$38.8M +85,530 New
Fidelity Investments
4
Fidelity Investments
Massachusetts
$45.8M +$33.3M +73,415 New
HP
5
Harbourvest Partners
Massachusetts
$35.6M +$25.9M +56,980 New
APM
6
Avidity Partners Management
Texas
$33M +$24M +52,923 New
GGHC
7
Gilder Gagnon Howe & Co
New York
$31.8M +$23.1M +50,941 New
MIM
8
Monashee Investment Management
Massachusetts
$27M +$19.6M +43,202 New
SFM
9
Sphera Funds Management
Israel
$26.1M +$19.8M +43,651 New
State of Wisconsin Investment Board
10
State of Wisconsin Investment Board
Wisconsin
$24.5M +$17.8M +39,202 New
Wellington Management Group
11
Wellington Management Group
Massachusetts
$23.7M +$17.2M +37,982 New
AG
12
Artal Group
Luxembourg
$13.3M +$9.63M +21,231 New
SAM
13
Sectoral Asset Management
Quebec, Canada
$10.8M +$7.85M +17,308 New
American Century Companies
14
American Century Companies
Missouri
$6.94M +$5.05M +11,121 New
PA
15
Perceptive Advisors
New York
$6M +$4.36M +9,615 New
UBS AM
16
UBS AM
Illinois
$6M +$4.36M +9,615 New
Millennium Management
17
Millennium Management
New York
$5.4M +$3.92M +8,645 New
Victory Capital Management
18
Victory Capital Management
Texas
$3.27M +$2.37M +5,231 New
Squarepoint
19
Squarepoint
New York
$1.92M +$1.4M +3,077 New
CCM
20
CAAS Capital Management
New York
$1.68M +$1.22M +2,692 New
Goldman Sachs
21
Goldman Sachs
New York
$1.68M +$1.22M +2,692 New
Vanguard Group
22
Vanguard Group
Pennsylvania
$1.68M +$1.22M +2,692 New
WP
23
Woodline Partners
California
$1.56M +$1.13M +2,495 New
Teacher Retirement System of Texas
24
Teacher Retirement System of Texas
Texas
$1.44M +$1.05M +2,308 New
MWNA
25
Marshall Wace North America
New York
$1.25M +$908K +2,001 New
1
2

SGTX Hedge Fund Activity: Q4 2020 in Review

45 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Sigilon Therapeutics, Inc. Common Stock (SGTX) for Q4 2020, worth a combined $942M.

Buyers outnumbered sellers: 45 funds opened new SGTX positions and 0 closed out — a net gain of 45 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Flagship Pioneering, opening a new position worth an estimated $362M.

  • 45 institutional investors held Sigilon Therapeutics, Inc. Common Stock (SGTX) as of Q4 2020, up from 0 in Q3 2020.
  • Funds reported $942M of Sigilon Therapeutics, Inc. Common Stock stock for Q4 2020.
  • 45 funds opened new Sigilon Therapeutics, Inc. Common Stock positions in Q4 2020 and 0 closed out, a net change of +45 holders.
  • The largest Sigilon Therapeutics, Inc. Common Stock buyer in Q4 2020 was Flagship Pioneering, an estimated $362M added.

Based on aggregated 13F filings for Q4 2020.